The Journal of urology
-
The Journal of urology · Oct 2013
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin.
Prior phase II studies of intravesical gemcitabine have shown it to be active and well tolerated, but durable responses in patients with nonmuscle invasive bladder cancer who have experienced recurrence after bacillus Calmette-Guérin treatment are uncommon. We performed a multi-institutional phase II study within the SWOG (Southwest Oncology Group) cooperative group to evaluate the potential role of gemcitabine induction plus maintenance therapy in this setting. ⋯ Intravesical gemcitabine has activity in high risk nonmuscle invasive bladder cancer and offers an option for patients with recurrence after bacillus Calmette-Guérin who are not suitable for cystectomy. However, less than 30% of patients had a durable response at 12 months even with maintenance therapy.
-
The Journal of urology · Oct 2013
Randomized Controlled TrialImproving patient knowledge about sacral nerve stimulation using a patient based educational video.
We developed a patient based educational video to address the information needs of women considering sacral nerve stimulation for overactive bladder. ⋯ Women with overactive bladder considering sacral nerve stimulation therapy have specific information needs. The video that we developed to address these needs was associated with improved short-term patient knowledge.
-
Hopes are high that the delivery system reforms embodied in the patient centered medical home will improve the quality of care for patients with chronic diseases. While primary care physicians, given their training, will likely be the locus of care under this model, there are certain conditions for which urologists are well suited to provide the continuous and comprehensive care called for by the patient centered medical home. To assess the feasibility of the urology based patient centered medical home, we analyzed national survey data. ⋯ Urology practices may possess the capacity needed to direct medical homes for their patients with genitourinary cancers. Successful implementation of this model would likely require a willingness to manage some nonurological conditions.
-
The Journal of urology · Oct 2013
Comparative StudyLearning curve of robotic assisted pyeloplasty for pediatric urology fellows.
Little is known about the learning curve of robotic surgery for surgeons in training. We hypothesized that pediatric urology fellows could attain proficiency in robotic pyeloplasty, defined as operative time equivalent to that of an experienced robotic surgeon, within the 2-year time frame of fellowship. ⋯ The operative time for robotic pyeloplasty performed by fellows consistently decreased with cumulative surgical experience. These data can be used to help establish benchmarks of robotic pyeloplasty for pediatric urology, assuming appropriate exposure to robotics and adequate case volume.
-
The Journal of urology · Oct 2013
Comparative StudyPediatric resident exposure to urology: identifying a need.
We evaluated current trends of pediatric urology exposure during the 3-year pediatric residency period nationwide. We also evaluated the opinions of urology and pediatric residency program directors regarding the need for additional exposure to pediatric urology. ⋯ These results show the desire on the part of urology and pediatric residency program directors for pediatric residents to have greater exposure to pediatric urology, particularly didactic and bedside teaching in the management of pediatric urological disorders. Increasing pediatric resident exposure to pediatric urological pathology and treatment during training would have a positive impact on the subsequent diagnosis and care of pediatric urological conditions.